About Gimv
Gimv is a private equity firm founded in 1980. It is primarily based in Antwerp, Belgium. As of Oct 2026, Gimv is an active investor with a portfolio of 272 companies, comprising 272 funding rounds and 47 acquisitions. In the last 12 months, it has participated in 4 funding rounds and has made 1 acquisition. The firm primarily invests in companies based in Belgium and United States. Its portfolio is spread across a wide range of sectors from Life Sciences to Enterprise Applications. Its latest investment was a $***** Post IPO round in Batenburg on Sep 09, 2026
Overall Gimv portfolio has seen 26 IPOs and 127 acquisitions, namely Evotec, Teads and Barco. A lot of funds co-invest with Gimv, with names like Life Sciences Partners sharing a substantial percentage of its portfolio.
Gimv has a team of 59 people, including 18 partners.
Key Metrics
Gimv's Portfolio
Gimv has a portfolio of 272 companies. They have invested in a total of 272 companies. Their most recent investment was in Batenburg (Post IPO round) on Sep 09, 2026. Here are the most recent investments by Gimv:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Sep 09, 2026 | Post IPO | 6721 | - | |
Jan 20, 2026 | Series B | 1588 | ||
Jan 12, 2026 | Series B | 8625 | ||
Nov 05, 2025 | PE | 5007 | - |
Gimv has acquired 47 companies. Their most recent acquisition was of Cap Vert on Jun 25, 2026. Here are the most recent acquisitions by Gimv:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jun 25, 2026 | Provider of urban landscaping services and pruning solutions | - | 2022 | |
Sep 02, 2025 | Geriatric home care consulting and services for nursing home sector | - | 2008 | |
Jul 22, 2025 | Provider of property maintenance services including sustainability, planning, and daily upkeep | - | 1958 | |
Apr 17, 2025 | Provider of incontinence and personal care products, and related services | - | - |
Here is the portfolio snapshot of Gimv:
Investments by Year
The maximum number of investments were made in 2017
Acquisitions by Year
The maximum number of acquisitions were made in 2018
Portfolio by Location
Companies are primarily in Belgium and United States
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of Gimv
Gimv has a team of 59 members including 18 Partners and 13 Principals located in Belgium, Germany and 3 more locations. Gimv's team does not sit on the board of any company as of now.Here is a list of top team members in Gimv:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Antwerp | - | ||
Partner | Brussels | - | - | |
Partner | Paris | - | ||
Partner | Berlin | - | ||
Partner | Antwerp | - | ||
Partner | Paris | - | ||
Partner | Paris | - | ||
Partner | Antwerp | - | ||
Partner | Antwerp | - | ||
Partner | Brussels | - | ||
Partner | Zurich | - |
Co-investors of Gimv
Over the past 46 years, 212 investors have co-invested in Gimv's portfolio companies.
- Top Co-investors of Gimv: 212 investors entered a company along with Gimv. These include investors like Life Sciences Partners (7 companies).
Gimv News
•
Gimv Anchor Invests in Dutch Industrial Tech Firm Batenburg Techniekhttps://newsnreleases.com•Sep 09, 2026•Batenburg, Gimv
•
Gimv Sells Majority Stake in AlpenBlu Clinics to Impact HealthcareLegal 500•Jul 03, 2026•Lespsyreunis, Gimv, Bar & Karrer
•
•
Gimv secures a new Revolving Credit Facility of EUR 400 million to support its accelerated growth ambitions.WebDisclosure•Mar 24, 2026•Kbc, Belfius, Gimv, ING Belgium and 1 other
•
•
•
EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance Alzheimer's therapyPR Newswire•Jan 20, 2026•Modi Ventures, CARMA FUND, Exciva, Landesbank Baden Wurttemberg and 6 others
•
•
EQT Life Sciences Backs Kinaset Therapeutics' USD103 Million Series BPR Newswire•Jan 12, 2026•Forge Life Science Partners, Kinaset Therapeutics, EQT, RA Capital Management and 8 others
